Avidicure
Latest round
- Seed
Last raised
- Apr 2025
Total raised
- $50M
Investors
- 6
About Avidicure
V.V. specializes in biopharmaceutical innovations, particularly in the field of oncology." These antibodies are engineered to modulate the immune system, effectively targeting both innate and adaptive immune responses to fight various cancers. Their flagship product, AVC-S-101, is under development for non-small cell lung cancer and other indications. Avidicure's AVC-Booster platform utilizes a proprietary antibody scaffold integrated with co-stimulatory domains to stimulate immune responses specifically within the tumor microenvironment, thus enhancing therapeutic efficacy while reducing systemic toxicity risks.Avidicure's revenue model is built around partnerships with healthcare providers and research organizations, engaging primarily in business-to-business transactions. The company supplies its AVC-Boosters to hospitals, oncology clinics, and pharmaceutical firms involved in cancer treatment development. Revenue is generated from AVC-Booster sales, with potential additional income from strategic partnerships involving milestone payments or royalties linked to successful product development and commercialization.V. The company plans to expand its product offerings and is exploring new markets, particularly in North America and Europe, enhancing its reach within the oncology sector. The funds will be utilized to support the creation of innovative treatments that address unmet needs in cancer care.
Who invested in Avidicure
6 investors across 1 round
See all investors in Avidicure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 14, 2025
Amount
$50M
Investors
Questions about Avidicure
Who invested in Avidicure?
Avidicure has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avidicure raised?
Avidicure has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Avidicure last raise money?
Avidicure's most recent round on record is a Seed, in Apr 2025.
What does Avidicure do?
Avidicure is a healthcare company.
Where is Avidicure headquartered?
Avidicure is headquartered in Oegstgeest, Netherlands.
Which VCs invest in companies like Avidicure?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Avidicure's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Avidicure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.